4//SEC Filing
Ronsheim Matthew 4
Accession 0001104659-24-032002
CIK 0001080014other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 7:02 PM ET
Size
8.6 KB
Accession
0001104659-24-032002
Insider Transaction Report
Form 4
Innoviva, Inc.INVA
Ronsheim Matthew
See Remarks
Transactions
- Award
Non-statutory Stock Option
2024-03-05+27,338→ 120,438 totalExercise: $14.88From: 2025-02-20Exp: 2034-03-05→ Common Stock (27,338 underlying) - Award
Common Stock
2024-03-05$14.88/sh+12,768$189,988→ 40,778 total
Footnotes (2)
- [F1]The Reporting Person was granted a one time-based restricted stock unit ("RSU"). Twenty-five percent of the shares subject to the RSU shall vest on February 20, 2025, 6.25% on May 20, 2025, and an additional 6.25% on the final day of each 3-month period thereafter, provided the Reporting Person has provided continuous service to the Issuer through the applicable vesting date. The grant was approved by the Compensation Committee of the Board of Directors of the Company.
- [F2]25% of the options will vest on February 20, 2025 and the balance will vest in twelve (12) substantially equal installments thereafter on each three (3) month anniversary of the initial vesting date, in each case, subject to Dr. Ronsheim's continuous service through the applicable vesting date, with accelerated vesting (i) in the event of a "change in control" (as defined in the Issuer's 2012 Equity Incentive Plan) in which the options are not assumed or replaced, or (ii) in the event that Dr. Ronsheim experiences a termination of employment by the Innoviva, Inc. without "cause" or by Dr. Ronsheim for "good reason" (each as defined in Dr. Ronsheim's employment agreement) within 24 months following a "change in control," subject to an effective release of claims.
Documents
Issuer
Innoviva, Inc.
CIK 0001080014
Entity typeother
Related Parties
1- filerCIK 0001824386
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 7:02 PM ET
- Size
- 8.6 KB